Basics AbCellera Biologics Inc. IPO Date: December 11, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.26B Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.08% Avg Daily Range (30 D): $0.14 | 3.09% Avg Daily Range (90 D): $0.13 | 3.82% Institutional Daily Volume Avg Daily Volume: 2.21M Avg Daily Volume (30 D): 4.75M Avg Daily Volume (90 D): 5.52M Trade Size Avg Trade Size (Sh.): 159 Avg Trade Size (Sh.) (30 D): 228 Avg Trade Size (Sh.) (90 D): 286 Institutional Trades Total Inst.Trades: 1,200 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $1.01M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.04M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $.74M Avg Closing Volume: 201.5K     News Aug 14, 2025 @ 11:23 AM Prelude Cuts Q2 Losses and Costs 13% Source: Jesterai Jul 30, 2025 @ 5:00 PM Global Antibody Discovery Market to Observe Stupen... Source: Delveinsight Jun 13, 2024 @ 9:40 AM Down 57%, Is AbCellera Biologics a Buy on the Dip?... Source: newsfeedback@fool.com (Cory Renauer) May 8, 2024 @ 8:30 AM AbCellera Biologics (ABCL) Q1 2024 Earnings Call T... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 7, 2024 @ 10:05 PM AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.12 $-.15 Diluted EPS $-.12 $-.15 Revenue $ $ 17.08M $ 4.24M Gross Profit $ $ $ Net Income / Loss $ $ -34.73M $ -45.62M Operating Income / Loss $ $ -49.59M $ -62.66M Cost of Revenue $ $ $ Net Cash Flow $ $ -66.83M $ 2.94M PE Ratio